share_log

Needham Downgrades TransMedics Gr to Hold, Maintains Price Target to $109

Benzinga ·  Nov 22, 2024 18:19  · Ratings

Needham analyst Mike Matson downgrades TransMedics Gr (NASDAQ:TMDX) from Buy to Hold and maintains the price target from $109 to $109.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment